Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Mithra Pharmaceuticals Logo
Mithra Pharmaceuticals Growth Score
62
CB Rank
104774
Heat Score
64
Mithra Pharmaceuticals specializes in the development of women's health care products.
Founded
obfuscation
PublicPost-IPO Debt Liège, Liege, Belgium251-500 www.mithra.com/en/
Biotechnology
Health Care
Pharmaceutical
Overview

Mithra Pharmaceuticals
Total Funding
obfuscation
Growth Score
62
Heat Score
64

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score62
1 pts
in past quarter
Heat Score 64
22 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Mithra Pharmaceuticals

CB Rank
104774
Mithra Pharmaceuticals specializes in the development of women's health care products.
Founded
obfuscation
PublicPost-IPO Debt Liège, Liege, Belgium251-500 www.mithra.com/en/
Biotechnology
Health Care
Pharmaceutical

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation

Key People

Details

Legal Name Mithra Pharmaceuticals SA
Operating Status Active
Stock Symbol  EBR:MITRA
Company Type For Profit
Founders  François Fornieri
About the Company

Mithra Pharmaceuticals SA specializes in the development of women's health care products that are dedicated to the fields of contraception, fertility, and menopause. The two lead development candidates Estelle® (a fifth generation oral contraceptive) and Donesta® (a next generation hormone therapy) are built on Mithra's unique natural

estrogen platform, E4 (Estetrol).

Phone Number +32 4 349 28 22
Contact Email info@mithra.com
Predictions & Insights

Products & Services

Estelle®
A combined oral contraceptive pill used to prevent pregnancy in women.
Donesta®
A treatment for moderate to severe vasomotor symptoms associated with menopause.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Mithra Pharmaceuticals Logo
Post-IPO Debt - Mithra Pharmaceuticals
2
obfuscation
Highbridge Capital ManagementPost-IPO Debt
obfuscation
Post-IPO Debt - Mithra Pharmaceuticals Logo
Post-IPO Debt - Mithra Pharmaceuticals
2
obfuscation
Highbridge Capital ManagementPost-IPO Debt
obfuscation
Post-IPO Debt - Mithra Pharmaceuticals Logo
Post-IPO Debt - Mithra Pharmaceuticals
2
obfuscation
Highbridge Capital ManagementPost-IPO Debt
obfuscation
Post-IPO Debt - Mithra Pharmaceuticals Logo
Post-IPO Debt - Mithra Pharmaceuticals
2
obfuscation
Highbridge Capital ManagementPost-IPO Debt
obfuscation
Post-IPO Debt - Mithra Pharmaceuticals Logo
Post-IPO Debt - Mithra Pharmaceuticals
2
obfuscation
Highbridge Capital ManagementPost-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Mithra Pharmaceuticals Logo
Post-IPO Debt - Mithra Pharmaceuticals
2
obfuscation
Highbridge Capital ManagementPost-IPO Debt
obfuscation
Post-IPO Debt - Mithra Pharmaceuticals Logo
Post-IPO Debt - Mithra Pharmaceuticals
2
obfuscation
Highbridge Capital ManagementPost-IPO Debt
obfuscation
Post-IPO Debt - Mithra Pharmaceuticals Logo
Post-IPO Debt - Mithra Pharmaceuticals
2
obfuscation
Highbridge Capital ManagementPost-IPO Debt
obfuscation
Post-IPO Debt - Mithra Pharmaceuticals Logo
Post-IPO Debt - Mithra Pharmaceuticals
2
obfuscation
Highbridge Capital ManagementPost-IPO Debt
obfuscation
Post-IPO Debt - Mithra Pharmaceuticals Logo
Post-IPO Debt - Mithra Pharmaceuticals
2
obfuscation
Highbridge Capital ManagementPost-IPO Debt

Investors

Investments

Number of Acquisitions 2

Investment Breakdown

Number of Acquisitions 2
Market Intelligence
People
View Profiles & Contacts
Headcount 251-500 Employee Profiles 2 Contacts 55

Employee Profiles

News

News and Press

News•Jul 17, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 24, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 3, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$4.5MThis year, Mithra Pharmaceuticals is projected to spend $4.5M on IT, according to Aberdeen.

Actively Used Products

14Mithra Pharmaceuticals uses 14 technology products and services including HTML5, Google Maps API, and  Google Analytics, according to G2 Stack.

Active Website Tech Count

37Mithra Pharmaceuticals is actively using 37 technologies for its website, according to BuiltWith. These include HSTS, DNSSEC, and  Google Tag Manager.

Total IP

8The intellectual property of Mithra Pharmaceuticals includes 7 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Mithra Pharmaceuticals has 1 registered trademark in the 'Bleaching, cleaning, polishing, scouring and abrasive preparations; cosmetics' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Mithra Pharmaceuticals's headquarters? Mithra Pharmaceuticals is located in Liège, Liege, Belgium.Who invested in Mithra Pharmaceuticals? Mithra Pharmaceuticals has 4 investors including Highbridge Capital Management and  Whitebox Advisors.When was the last funding round for Mithra Pharmaceuticals? Mithra Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Mithra Pharmaceuticals's competitors? Alternatives and possible competitors to Mithra Pharmaceuticals may include Gynial, idConsulting Switzerland, and  Nutreov.How much funding has Mithra Pharmaceuticals raised to date? Mithra Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f8e1fc8 1)
|